National Institute of Health (NIH), after analyzing weights and cardiovascular, metabolic risk factors a year after suspending the Wegovy treatment, patients regained two-thirds of the lost weight on average, and their cardiovascular, metabolic risk factors also returned to similar levels to changed weights
89, # 6, p
That more GH signaling is inherently beneficial for longevity or metabolic health
To Lisas point, too, they go over the evidence-based treatment, but also evidence-based lifting modifications and behavioral things thats evidence-based
Infused with 6 types of peptides for deep nourishment and enhanced elasticity
Clinical trials have demonstrated that patients taking Wegovy typically experience around 15% reduction in body weight on average at 68 weeks in trials (with variation among individuals) , largely attributed to decreased calorie intake resulting from these appetite-suppressing effects, as shown in the STEP 1 trial